Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical research reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies to develop companion imaging agents for therapeutic antibody products

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/27/12	undisclosed	Series A	Cycad Group Merieux Developpement Momentum Biosciences Nextech Invest Novartis Venture Funds	undisclosed
05/09/14	$21,000,000	Series B	Cycad Group Merieux Developpement Nextech Invest Novartis Venture Funds	undisclosed
10/09/17	$8,000,000		Adage Capital Management Cycad Group Nextech Invest NVF Parker Institute for Cancer Immunotherapy Raptor Group	undisclosed